(Q35057231)

6 August 2017

1 reference

title

Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease (English)

1 reference

6 August 2017

Bjartmar C

1

1 reference

6 August 2017

Wujek JR

series ordinal

2

1 reference

6 August 2017

Trapp BD

series ordinal

3

1 reference

6 August 2017

publication date

1 February 2003

1 reference

Journal of the Neurological Sciences

6 August 2017

published in

1 reference

6 August 2017

volume

206

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

165-171

1 reference

Neuropathology in multiple sclerosis: new concepts

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Pathogenesis of tissue injury in MS lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Axonal pathology in multiple sclerosis. A historical note

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Axonal damage in acute multiple sclerosis lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Axonal Transection in the Lesions of Multiple Sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Glutamate excitotoxicity in a model of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Clonal expansions of CD8( ) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

A pathogenic role for myelin-specific CD8( ) T cells in a model for multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Electrically active axons degenerate when exposed to nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Compression injury of mammalian spinal cord in vitro and the dynamics of action potential conduction failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Spinal cord axonal loss in multiple sclerosis: a post-mortem study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Axonal changes in chronic demyelinated cervical spinal cord plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Axonal loss in normal-appearing white matter in a patient with acute MS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

A Wallerian degeneration pattern in patients at risk for MS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Selecting relapsing remitting multiple sclerosis patients for treatment: the case for early treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Axonal pathology in myelin disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Axonal pathology in demyelinating diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Myelin-Associated Glycoprotein Is a Myelin Signal that Modulates the Caliber of Myelinated Axons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Axonal swellings and degeneration in mice lacking the major proteolipid of myelin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Acquired channelopathies in nerve injury and MS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Total brain N-acetylaspartate: a new measure of disease load in MS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Imaging axonal damage of normal-appearing white matter in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Recent views on amyotrophic lateral sclerosis with emphasis on electrophysiological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

The role of CD45 and CD45‐associated molecules in T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Relapses and progression of disability in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

The distribution of plaques in the cerebrum in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Cortical lesions in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Multiple sclerosis: a white matter disease with associated gray matter damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

CNS compensation to dopamine neuron loss in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(02)50069-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(02)00069-2

1 reference

6 August 2017

1 reference